Logo image of MDGL

MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:MDGL - US5588681057 - Common Stock

501.68 USD
+5.8 (+1.17%)
Last: 1/16/2026, 8:00:01 PM
501.68 USD
0 (0%)
After Hours: 1/16/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MDGL revenue by date.MDGL revenue by date.
180.133M964.82M
435.62%
1.473B
52.67%
2.208B
49.90%
2.99B
35.42%
4.004B
33.91%
4.926B
23.03%
5.733B
16.38%
6.48B
13.03%
6.519B
0.60%
EBITDA
YoY % growth
MDGL ebitda by date.MDGL ebitda by date.
-293.13M
-21.08%
-379.969M
-29.62%
-496.779M
-30.74%
-293.865M
40.85%
49.804M
116.95%
447.42M
798.36%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MDGL ebit by date.MDGL ebit by date.
-293.6M
-21.07%
-380.496M
-29.60%
-497.875M
-30.85%
-298.216M
40.10%
20.043M
106.72%
512.98M
2,459.40%
1.172B
128.47%
2.025B
72.78%
2.701B
33.38%
3.256B
20.55%
3.754B
15.29%
3.676B
-2.08%
Operating Margin
MDGL operating margin by date.MDGL operating margin by date.
N/AN/A-276.39%-30.91%1.36%23.23%39.20%50.57%54.83%56.79%57.93%56.39%
EPS
YoY % growth
MDGL eps by date.MDGL eps by date.
-17.23
-17.93%
-19.94
-15.73%
-22.11
-10.88%
-10.77
51.27%
1.62
115.00%
19.91
1,132.04%
38.24
92.03%
59.62
55.92%
70.41
18.10%
90.71
28.84%
105.81
16.64%
110.86
4.77%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.58
78.68%
-0.85
74.39%
0.30
115.85%
1.13
122.77%
1.99
444.56%
5.37
730.97%
8.58
2,748.58%
11.33
903.00%
14.10
608.51%
Revenue
Q2Q % growth
316.44M
206.27%
312.08M
127.38%
357.62M
68.05%
396.41M
37.99%
435.99M
37.78%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-82.199M
-24.73%
-19.541M
75.24%
20.287M
143.68%
35.953M
131.86%
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-19.127M
71.45%
-24.639M
68.93%
5.7M
112.08%
28.048M
124.61%
53.792M
381.24%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-4.96
-0.81%
-2.12-2.84-133.61%
Q2 2025
Q2Q % growth
-1.90
73.24%
-3.711.8148.79%
Q1 2025
Q2Q % growth
-3.32
55.01%
-3.840.5213.46%
Q4 2024
Q2Q % growth
-2.71
52.29%
-4.331.6237.40%
Q3 2024
Q2Q % growth
-4.92
7.87%
-7.052.1330.22%
Q2 2024
Q2Q % growth
-7.10
-51.39%
-7.680.587.50%
Q1 2024
Q2Q % growth
-7.38
-74.47%
-6.41-0.97-15.12%
Q4 2023
Q2Q % growth
-5.68
-14.06%
-5.39-0.29-5.38%
Q3 2023
Q2Q % growth
-5.34
-12.42%
-5.02-0.32-6.30%
Q2 2023
Q2Q % growth
-4.69
-13.29%
-4.67-0.02-0.37%
Q1 2023
Q2Q % growth
-4.23
-25.89%
-5.040.8116.00%
Q4 2022
Q2Q % growth
-4.98
-31.75%
-4.65-0.33-7.16%
Q3 2022
Q2Q % growth
-4.75
-25.33%
-4.24-0.51-12.11%
Q2 2022
Q2Q % growth
-4.14
-11.29%
-3.77-0.37-9.78%
Q1 2022
Q2Q % growth
-3.36
-1.20%
-3.690.339.02%
Q4 2021
Q2Q % growth
-3.78
1.05%
-3.950.174.41%
Q3 2021
Q2Q % growth
-3.79
-1.07%
-3.980.194.67%
Q2 2021
Q2Q % growth
-3.72
-16.98%
-3.66-0.06-1.75%
Q1 2021
Q2Q % growth
-3.32
-41.88%
-3.920.6015.32%
Q4 2020
Q2Q % growth
-3.82 -3.930.112.85%
Q3 2020
Q2Q % growth
-3.75 -3.36-0.39-11.47%
Q2 2020
Q2Q % growth
-3.18 -2.50-0.68-27.07%
Q1 2020
Q2Q % growth
-2.34 -1.98-0.36-18.07%
MDGL Yearly EPS VS EstimatesMDGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 -20 40 60 80 100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
287.268M
362.03%
252.25M35.018M13.88%
Q2 2025
Q2Q % growth
212.802M
1,353.76%
165.56M47.242M28.53%
Q1 2025
Q2Q % growth
137.25M 116.1M21.15M18.22%
Q4 2024
Q2Q % growth
103.32M 100.53M2.79M2.78%
Q3 2024
Q2Q % growth
62.175M 34.873M27.302M78.29%
Q2 2024
Q2Q % growth
14.638M 3.981M10.657M267.70%
MDGL Yearly Revenue VS EstimatesMDGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-155.41% 79.25% -5.93% -5.1%
Revenue-0.24% 11.74% -0.08% 8.41%